About Sem-P (Semaglutide) Sem-P (Semaglutide) is GLP-1 receptor agonist used to Helps control blood sugar in Type 2 Diabetes Mellitus (with diet & exercise) Reduces risk of major cardiovascular events (heart attack, stroke, death) in high-risk patients Supports chronic weight management in: Obesity Overweight with comorbidities (e.g., hypertension, diabetes, dyslipidemia) Used in MASH (Metabolic Dysfunction-Associated Steatohepatitis)
1 st digital longevity clinic We pioneered modern longevity care, making it accessible to all
Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases
Consult your physician before ordering any drug since medicines can have dangerous side effects and specific interactions with other diseases
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Still, the specific complaints paint a consistent picture that goes beyond typical dissatisfaction